NSE IPO's grey market premium fell from Rs. 145 to under Rs. 50 by the final bidding day. Here is what the compressed GMP and late subscription surge actually mean.
If you've been tracking the NSE IPO's grey market premium over the past few days, you've probably felt a bit of whiplash. The GMP that had retail investors excited before listing has fallen sharply since bidding actually opened, and for most of the final day it was sitting under Rs. 50, a fraction of where it started. If you're deciding whether to apply in these last few hours, it's worth understanding exactly what happened before you let one number make the decision for you.
We covered the run-up to this moment in our piece on NSE IPO with 3 days left to apply, and the picture has shifted meaningfully since then.
The trajectory here tells its own story better than any single snapshot. NSE's grey market premium stood at around Rs. 145 on September 16, the day before bidding opened, a level that implied a healthy listing pop over the Rs. 1,785 upper price band. It held reasonably steady at Rs. 142 once bidding actually began on September 17. From there, it fell fairly consistently, to Rs. 111 by September 18, then a sharper drop to Rs. 61 on September 19, and down to Rs. 48 by September 20, where it largely stayed through the morning of the final day.
| Date | GMP | Implied Premium |
| Sept 16 (pre-listing) | Rs. 145 | ~8.1% |
| Sept 18 (Day 2) | Rs. 111 | ~6.2% |
| Sept 20 | Rs. 48 | ~2.7% |
| Sept 21, later afternoon | Rs. 70 | ~3.9% |
NSE IPO's GMP Trajectory
Grey market premium, in Rs. per share
145
Sept 16
111
Sept 18
61
Sept 19
48
Sept 20
70
Sept 21 PM
GMP figures from grey market trackers, unofficial and subject to change until listing
A near 65 percent fall in GMP over four bidding days sounds alarming in isolation, but it makes more sense once you factor in the backdrop this IPO has actually opened into. We've been tracking a genuinely rough stretch for Indian markets recently, including our coverage of markets falling for a fourth straight week. A large IPO landing during a period of broader market weakness tends to see its grey market premium compress simply because overall risk appetite is lower across the board, not necessarily because sentiment on the specific company has soured.
It's also worth remembering how we got to this exact price band in the first place. We covered in detail how NSE's IPO price band came in lower than earlier expected, which already priced in a fair amount of the value gap between the IPO and unlisted market levels before bidding even opened. When a price band is already set conservatively, there is naturally less room left for the GMP to run compared to an IPO priced more aggressively against unlisted levels.
Here is the detail that actually matters more than the GMP number on its own. Subscription data through the bidding window shows a clear and consistent pattern, retail investors have been notably more cautious than institutional ones. The retail portion was subscribed only 0.69 times by Day 2, still lagging at 0.88 times even deep into the final day, while qualified institutional buyers moved from 1.32 times to 1.83 times over the same stretch, and non-institutional investors surged from 1.46 times to as high as 2.34 times. Overall subscription jumped from just 1.04 times early on the final day to 2.38 times by early afternoon, almost entirely on the back of institutional and high-net-worth demand rushing in late.
This is a meaningful decoupling. Retail sentiment, which tends to track the visible GMP number closely, stayed cautious. Institutional money, which typically looks past grey market noise toward the underlying business and long-term valuation, came in strongly anyway. That divergence tells you something the GMP number alone does not.
This is exactly the kind of situation our earlier piece on whether you can trust IPO grey market premiums was written for. GMP is a genuinely useful sentiment indicator, but it is also unofficial, thinly traded, and prone to swinging sharply on very little actual volume, exactly what appears to have happened here between the Rs. 48 low and the Rs. 70 recovery within the same single day. Treating a number that moves this much within hours as a precise listing-day forecast is asking more of it than it can reliably deliver.
A more useful framework is to separate two different questions. First, do you believe in NSE as a business over the next few years, given its dominant position, its scale, and the fact that this is genuinely a rare opportunity to own India's primary stock exchange directly. Second, are you comfortable with a listing-day outcome that could realistically be anywhere from a modest single-digit gain to roughly flat, rather than the double-digit pop the pre-listing GMP once implied. If your answer to the first question is yes, a compressed GMP on the final day is a reason for tempered expectations, not necessarily a reason to skip the IPO altogether. If you were only ever interested in a quick listing-day flip based on the early Rs. 145 GMP, that specific trade has already gotten considerably less attractive.
If you're applying today, it's worth reviewing the mechanics one more time in our NSE IPO subscription guide covering lot size and allotment strategy, and remembering that these subscription and GMP figures can keep shifting right up until the retail and employee bidding window closes later this evening, so treat any single snapshot, including the numbers in this piece, as a point-in-time read rather than the final word.
This article is for informational purposes only and should not be construed as investment advice. IPO grey market premiums are unofficial and do not guarantee listing performance. Please verify current subscription and GMP data before making any investment decision.
NSE IPO's grey market premium fell from around Rs. 145 before listing opened to under Rs. 50 for most of the final bidding day, before recovering to around Rs. 70 later in the day.
Retail investors tend to track the visible GMP number closely and stayed cautious as it compressed, while institutional investors, who typically focus on long-term valuation, subscribed much more aggressively.
Not necessarily. GMP is an unofficial, thinly traded indicator that can swing sharply on limited volume, so it should be one input alongside the company's fundamentals rather than the sole deciding factor.
Allotment is expected to be finalised on September 22, 2026, with shares scheduled to list on the BSE on September 24, 2026.
Overall subscription rose sharply through the final day, moving from just over 1 time subscribed in the morning to over 2 times subscribed by early afternoon, driven mainly by institutional and non-institutional demand.